Finally, and consistent with previous study,48 we found Triggering Receptor Expressed On Myeloid Cells 2 (TREM2) in the G4 (down-up), which showed a decrease from controls to the asymptomatic stage but then significantly elevated levels are noticed in AD individuals. This evidence concerns the gene TREM2 and Alzheimer disease.